Japanese Scientists Identify Novel Alzheimer's Trigger, Peak 1 Aβ, with Potential Therapeutic Implications
Scientists in Japan have identified a distinct, high-molecular-weight form of soluble amyloid-beta, termed 'Peak 1 Aβ,' which acts as an aggressive seed for amyloid deposition in experimental models of Alzheimer's disease. This discovery, published in the journal Brain Communications, suggests that Peak 1 Aβ could be a candidate molecular driver of beta-amyloidosis, a key component of Alzheimer's pathology. The research team, comprising members from the National Center of Neurology and Psychiatry, the University of Tokyo, Niigata University, and Massachusetts General Hospital, studied soluble amyloid-beta species in brain tissue from mice and humans. They found that only Peak 1 Aβ, among three identified fractions, induced substantial amyloid-beta deposition when injected into the hippocampus of young transgenic mice. Furthermore, Peak 1 Aβ levels increased with age in these mice, correlating with insoluble amyloid-beta. The study also detected Peak 1 Aβ in autopsied brain samples from individuals with pat... 
